MRI and CT are valuable noninvasive imaging modalities for the characterization, treatment planning, and follow-up of cardiac and paracardiac masses.
Supports MRI/CT preference for precise mass delineation in practice; extends observational data but leaves open prospective outcome validation.
Magnetic resonance imaging (MRI) and computed tomography (CT) are important imaging modalities for the noninvasive characterization of cardiac and paracardiac masses. They are, in general, superior to other modalities (e.g., echocardiography) in their ability to delineate the exact location and the extent of the lesion and to demonstrate the effects of the lesion on surrounding structures. MRI and CT may also be helpful in suggesting a specific diagnosis, because some tumors have rather characteristic locations and appearances. In addition, both modalities can be extremely helpful in both treatment planning and posttreatment follow-up because they are noninvasive, reproducible, and enable detection of residual or recurrent mass.
No takes yet. Share an insight, caveat, or question.
Schvartzman et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: